← Back to Search
Lipid-polymer Hybrid Nanoparticles: Synthesis Strategies And Biomedical Applications.
V. Dave, Kajal Tak, Amit Sohgaura, A. Gupta, Veera Sadhu, K. R. Reddy
Published 2019 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
This review article is an updated overview on lipid-polymer hybrid nanoparticles (LPHNs) including the various types of LPHNs polymers used in their preparation, various methods of preparation, their physiochemical, in-vitro and in-vivo evaluation parameters and their application in various delivery systems. LPHNs show a combined advantage of biodegradable polymeric nanoparticles and liposomes. LPHNs mainly consist of a biodegradable polymeric material core containing drugs or any substances which are to be encapsulated then this core is further enclosed by a phospholipid layer i.e. lipid PEG layer. LPHNs show good physical strength and biocompatibility. The hybrid structural design can offer various benefits such as controlled particle size, high drug loading, surface functionality with various ligands (antibody fragments, peptides, monoclonal antibodies, aptamers, and folate molecules), and encapsulation of combinational therapeutic agents, showing prolonged release of drug and drug circulates in the blood for longer duration. Significantly, the LPHNs have recently been confirmed as a better drug delivery route and good cellular delivery efficacy of various drugs as compared to polymeric nanoparticles and liposomes.
This paper references
In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
H. L. Wong (2007)
Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells.
C. Hu (2010)
PLGA/polymeric liposome for targeted drug and gene co-delivery.
H. Wang (2010)
Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles.
Y. Li (2008)
Production of hybrid lipid-based particles loaded with inorganic nanoparticles and active compounds for prolonged topical release.
C. García-González (2009)
The comparison of protein-entrapped liposomes and lipoparticles: preparation, characterization, and efficacy of cellular uptake
W. Chang (2011)
In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles.
Xingfang Su (2011)
Chemotherapeutic engineering : Vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168h in vivo
S. Feng (2007)
Towards safe, non-viral therapeutic gene expression in humans
D. Glover (2005)
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
M. Aldosari (2009)
Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.
Warefta Hasan (2012)
Polymer-supported lipid shells, onions, and flowers.
A. Bershteyn (2008)
Development of a respirable, sustained release microcarrier for 5-fluorouracil I: In vitro assessment of liposomes, microspheres, and lipid coated nanoparticles.
C. Hitzman (2006)
Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system
V. Dave (2017)
LIPID–POLYMER HYBRID NANOPARTICLES: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS
Li I. Zhang (2010)
Polymer-caged lipsomes: a pH-responsive delivery system with high stability.
S. Lee (2007)
A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
Y. Wang (2012)
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
L. Zhang (2008)
Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles
Wean Sin Cheow (2012)
Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids.
Julie Thévenot (2007)
Nanoparticles by spray drying using innovative new technology: the Büchi nano spray dryer B-90.
X. Li (2010)
Combinatorial drug conjugation enables nanoparticle dual-drug delivery.
S. Aryal (2010)
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Laura M Ensign (2012)
Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine
J. Moon (2012)
Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging.
A. Mieszawska (2012)
Drug delivery to eye: Special reference to nanoparticles
Swarnali Das (2010)
Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells.
Y. Zheng (2010)
An overview of current delivery systems in cancer gene therapy.
Anas El-Aneed (2004)
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
Recent advances in controlled pulmonary drug delivery.
Zhenglin Liang (2015)
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
Guo Chen-yu (2012)
A New Drug Vehicle - Lipid Coated Biodegradable Nanoparticles
J. Schäfer (2008)
Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Peiqi Zhao (2012)
Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.
Dana J Gary (2007)
A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
M. Narvekar (2012)
Magnetic field activated lipid-polymer hybrid nanoparticles for stimuli-responsive drug release.
S. D. Kong (2013)
Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
Chih-Hang Chu (2011)
Targeting of nanoparticles: folate receptor.
Sumith A. Kularatne (2010)
Polyethylene Glycol-Conjugated Copolymers for Plasmid DNA Delivery
M. Lee (2004)
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Shiladitya Sengupta (2005)
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
R. Mueller (2002)
Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform.
B. Mandal (2013)
Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA.
J. Heyes (2007)
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
C. Hu (2011)
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Wean Sin Cheow (2011)
Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
G. Ling (2010)
Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs
R. Gurny (1981)
Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.
Y. Liu (2010)
Preparation and encapsulation of highly fluorescent conjugated polymer nanoparticles.
C. Wu (2006)
siRNA delivery systems for cancer treatment.
Yu-Kyoung Oh (2009)
In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid–polymeric nanoparticles
J. M. Chan (2011)
Current concepts: Nanomedicine
Betty Y. S. Kim (2010)
Effect of the polymer nature on the structural organization of lipid/polymer particle assemblies.
Julie Thévenot (2008)
Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups.
Carolina Salvador-Morales (2009)
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Y. Liu (2010)
Liposomes in drug delivery: Progress and limitations
Amarnath Sharma (1997)
Increased Resistance of DNA Lipoplexes to Protein Binding In Vitro by Surface-modification with a Multivalent Hydrophilic Polymer
I. Papanicolaou (2004)
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression.
E. Ambegia (2005)
Nanoparticle delivery for transdermal HRT.
P. Valenzuela (2012)
pH‐Triggered Thermally Responsive Polymer Core–Shell Nanoparticles for Drug Delivery
K. Soppimath (2005)
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Kunn Hadinoto (2013)
Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
Sylvia K E Messerschmidt (2009)
Engineering liposomes for drug delivery: progress and problems.
G. Gregoriadis (1995)
Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.
Elizabeth M. Enlow (2011)
PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium
M. Bivas-Benita (2004)
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yeonhee Yun (2013)
ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation.
A. Wang (2010)
Pulmonary Drug Metabolism, Clearance, and Absorption
Bo Olsson (2011)
New insights into self-organization of a model lipid mixture and quantification of its adsorption on spherical polymer particles.
Anne-Lise Troutier (2005)
Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing.
P. Valencia (2010)
Biodegradable nanoparticles for drug delivery and targeting
M. Hans (2002)
Physicochemical and interfacial investigation of lipid/polymer particle assemblies.
Anne-Lise Troutier (2005)
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
J. M. Chan (2009)
Molecular Mechanisms of RNA-Triggered Gene Silencing Machineries
Zhonghan Li (2012)
Supramolecular biovectors (SMBV): a new family of nanoparticulate drug delivery systems. Synthesis and structural characterization
M. Peyrot (1994)
The effect of nanoparticle size, shape, and surface chemistry on biological systems.
Alexandre Albanese (2012)
Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery.
J. Shi (2011)
A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells
H. L. Wong (2006)
This paper is referenced by
Comprehensive Survey on Nanobiomaterials for Bone Tissue Engineering Applications
P. Kumar (2020)
Self-assembled drug loaded glycosyl-protein metal nanoconstruct: Detailed synthetic procedure and therapeutic effect in solid tumor treatment.
B. Unnikrishnan (2020)
Polymeric nanocarriers in targeted drug delivery systems: A review
Payam Abasian (2020)
Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy
Ayeskanta Mohanty (2020)
Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies.
Chih Kit Chung (2020)
Cationic Nanostructures for Vaccines Design
Ana Carolina Carmona-Ribeiro (2020)
Biocompatible Hydrotalcite Nanohybrids for Medical Functions
Wenji Jin (2020)
Nanomaterials as potential transporters of HDAC inhibitors
C. D. Souza (2020)
pH-responsive lipid polymer hybrid nanoparticles (LPHNs) based on poly (β-amino ester) as a promising candidate to resist breast cancers
H. Zhang (2020)
Nose-to-brain delivery of antipsychotics using nanotechnology: a review
Madeleine Sa Tan (2020)
Multicomponent and 1,3-dipolar cycloaddition synthesis of triazole- and isoxazole-acridinedione/xanthenedione heterocyclic hybrids: Cytotoxic effects on human cancer cells
Abdelkader Naouri (2020)
Nanodiamonds and their surface modification strategies for drug delivery applications
U. T. Uthappa (2020)
Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
Jana Ghitman (2020)
Lipid-core/polymer-shell hybrid nanoparticles: synthesis and characterization by fluorescence labeling and electrophoresis.
Sophie Bou (2020)
Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice.
Sudeep Sudesh Pukale (2020)
Nanohybrid carriers: the yin-yang equilibrium between natural and synthetic in biomedicine.
F. Ghorbanizamani (2020)
Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
Kuldeep Rajpoot (2020)
The Efficacy of Cholesterol-Based Carriers in Drug Delivery
Ngonidzashe Ruwizhi (2020)
Single and Multi-metal Oxide Nanoparticles Induced Cytotoxicity and ROS Generation in Human Breast Cancer (MCF-7) Cells
M. A. Siddiqui (2020)
The Viscosity Behaviour of PEGylated Locust Bean Gum/Rosin Ester Polymeric Nanoparticles
Selcan Karakuş (2019)
Morphological, structural and cytotoxic behavior of starch/silver nanocomposites with synthesized silver nanoparticles using Stevia rebaudiana extracts
M. Valera-Zaragoza (2020)
Material, Immunological, and Practical Perspectives on Eye Drop Formulation
Naomi H. Bennett (2020)
Systemic Review of Biodegradable Nanomaterials in Nanomedicine
S. Su (2020)
Preprint Title LIPID NANOPARTICLES FOR THE TRANSPORT OF DRUGS LIKE DOPAMINE THROUGH THE BLOOD–BRAIN BARRIER Authors
E. Ortega (2020)
Innovative Nanotechnological Formulations to Reach the Hepatic Stellate Cell
K. Poelstra (2020)
Molecular docking and inhibitory effects of a novel cytotoxic agent with bovine liver catalase
S. Shahraki (2020)
Interactions at engineered graft–tissue interfaces: A review
Wenzhen Zhu (2020)
Lipid Polymer Hybrid Nanoparticles: A Novel Approach for Drug Delivery
Nayab Tahir (2019)
Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA
C. Siewert (2020)
QbD based exploration of resveratrol loaded polymeric micelles based carbomer gel for topical treatment of plaque psoriasis: In vitro, ex vivo and in vivo studies
B. Khurana (2020)
Nanotechnology-based antiviral therapeutics
Malobika Chakravarty (2020)